7.83
price up icon0.13%   0.010
after-market アフターアワーズ: 8.24 0.41 +5.24%
loading
前日終値:
$7.82
開ける:
$7.72
24時間の取引高:
1.51M
Relative Volume:
0.88
時価総額:
$2.45B
収益:
$2.68B
当期純損益:
$-184.45M
株価収益率:
-11.51
EPS:
-0.6805
ネットキャッシュフロー:
$229.23M
1週間 パフォーマンス:
-2.85%
1か月 パフォーマンス:
-4.63%
6か月 パフォーマンス:
-5.21%
1年 パフォーマンス:
+9.05%
1日の値動き範囲:
Value
$7.665
$7.84
1週間の範囲:
Value
$7.665
$8.235
52週間の値動き範囲:
Value
$6.50
$9.475

Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile

Name
名前
Amneal Pharmaceuticals Inc
Name
セクター
Healthcare (1164)
Name
電話
908-947-3120
Name
住所
400 Crossing Boulevard, 3rd Floor, Bridgewater
Name
職員
5,210
Name
Twitter
@amnealpharma
Name
次回の収益日
2025-05-02
Name
最新のSEC提出書
Name
AMRX's Discussions on Twitter

AMRX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Specialty & Generic icon
AMRX
Amneal Pharmaceuticals Inc
7.83 2.45B 2.68B -184.45M 229.23M -0.6805
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
147.38 64.91B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.16 43.33B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.66 42.36B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
15.38 17.72B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
294.28 12.42B 2.99B 1.21B 1.13B 25.06

Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-06-06 開始されました Goldman Buy
2025-02-24 アップグレード JP Morgan Neutral → Overweight
2024-09-06 アップグレード JP Morgan Underweight → Neutral
2021-04-07 再開されました RBC Capital Mkts Sector Perform
2021-03-08 アップグレード Goldman Sell → Buy
2020-12-14 アップグレード Barclays Equal Weight → Overweight
2020-12-14 アップグレード Guggenheim Neutral → Buy
2020-07-27 開始されました Goldman Sell
2020-05-12 アップグレード Guggenheim Sell → Neutral
2019-12-12 ダウングレード Raymond James Outperform → Mkt Perform
2019-11-12 ダウングレード JP Morgan Neutral → Underweight
2019-11-07 ダウングレード SVB Leerink Outperform → Mkt Perform
2019-07-22 アップグレード SVB Leerink Mkt Perform → Outperform
2019-07-11 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2019-07-08 アップグレード Piper Jaffray Neutral → Overweight
2019-06-11 開始されました Barclays Equal Weight
2019-05-21 アップグレード Raymond James Mkt Perform → Strong Buy
2019-03-20 開始されました SunTrust Buy
2019-03-08 ダウングレード SVB Leerink Outperform → Mkt Perform
2018-12-14 ダウングレード Morgan Stanley Overweight → Equal-Weight
2018-10-16 ダウングレード SunTrust Buy → Hold
2018-08-13 アップグレード RBC Capital Mkts Sector Perform → Outperform
2018-07-23 開始されました Morgan Stanley Overweight
2018-06-22 開始されました B. Riley FBR, Inc. Buy
すべてを表示

Amneal Pharmaceuticals Inc (AMRX) 最新ニュース

pulisher
04:52 AM

Amneal Pharmaceuticals Secures $2.1 Billion in Loans - TipRanks

04:52 AM
pulisher
02:43 AM

How does Amneal Pharmaceuticals Inc. compare to its industry peersBest Dividend Report From AI Tools - jammulinksnews.com

02:43 AM
pulisher
Jul 31, 2025

What makes Amneal Pharmaceuticals Inc. stock price move sharplyBreakout Stocks Tips For Beginners - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

What is Amneal Pharmaceuticals Inc. company’s growth strategyBreakout Stocks Strategy With Low Risk - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

Truist Financial Maintains a Buy on Amneal Pharmaceuticals (AMRX) With an $8 PT - Insider Monkey

Jul 31, 2025
pulisher
Jul 31, 2025

How strong is Amneal Pharmaceuticals Inc. company’s balance sheetEntry Signal Growth Plan For Every Investor - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

Amneal Launches GLP-1 Agonist Exenatide Injection - Specialty Pharmacy Continuum

Jul 31, 2025
pulisher
Jul 30, 2025

Teva Drops Inhaler Patent Infringement Lawsuit Against Amneal - Bloomberg Law News

Jul 30, 2025
pulisher
Jul 30, 2025

Is Amneal Pharmaceuticals Inc. a candidate for recovery playReversal Alert Based on RSI Indicator Confirmed - metal.it

Jul 30, 2025
pulisher
Jul 30, 2025

Amneal Pharmaceuticals Inc. Company’s Quarterly Earnings Growth: What the Numbers SayStock Market Watch With Alerts Shows Unusual Activity - metal.it

Jul 30, 2025
pulisher
Jul 29, 2025

Teva, Amneal End Case Over Listing Inhaler IP In Orange Book - Law360

Jul 29, 2025
pulisher
Jul 29, 2025

Why Amneal Pharmaceuticals Inc. stock attracts strong analyst attentionAI Driven Stock Trend Forecast Shows Momentum Shift - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Amneal (AMRX) is an Incredible Growth Stock: 3 Reasons Why - sharewise.com

Jul 29, 2025
pulisher
Jul 29, 2025

Wall Street Analysts Think Amneal (AMRX) Could Surge 43.82%: Read This Before Placing a Bet - Zacks Investment Research

Jul 29, 2025
pulisher
Jul 29, 2025

Amneal Pharmaceuticals (AMRX) Earnings Expected to Grow: Should You Buy? - Yahoo Finance

Jul 29, 2025
pulisher
Jul 29, 2025

Q1 Earnings Highlights: Amneal, ANI, Amphastar, and ViatrisNews and Statistics - IndexBox

Jul 29, 2025
pulisher
Jul 29, 2025

Q1 Earnings Highs And Lows: Amneal (NASDAQ:AMRX) Vs The Rest Of The Generic Pharmaceuticals Stocks - Yahoo Finance

Jul 29, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-29 09:45:24 - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

Published on: 2025-07-28 20:38:28 - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Is Amneal Pharmaceuticals (AMRX) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Jul 28, 2025
pulisher
Jul 28, 2025

What are the technical indicators suggesting about Amneal Pharmaceuticals Inc.Capitalize on momentum stocks early - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Is Amneal Pharmaceuticals Inc. a growth stock or a value stockAchieve consistent profits with smart trading - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What institutional investors are buying Amneal Pharmaceuticals Inc. stockExceptional earning trajectories - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How does Amneal Pharmaceuticals Inc. generate profit in a changing economyUnlock high-yield investment opportunities - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

How many analysts rate Amneal Pharmaceuticals Inc. as a “Buy”Achieve rapid financial growth with expert picks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 26, 2025

How Amneal Pharmaceuticals Inc. stock performs during market volatilityFree Stock Selection with 300% Return - metal.it

Jul 26, 2025
pulisher
Jul 26, 2025

Truist Financial Sticks to Its Buy Rating for Amneal Pharmaceuticals (AMRX) - The Globe and Mail

Jul 26, 2025
pulisher
Jul 25, 2025

Amneal Pharmaceuticals Inc. Stock Analysis and ForecastMassive portfolio appreciation - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Amneal Pharmaceuticals Inc. stock priceFree Investment Community - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Amneal Pharmaceuticals Prices $600M Senior Notes Offering - MSN

Jul 25, 2025
pulisher
Jul 25, 2025

Truist Financial Maintains Amneal Pharmaceuticals(AMRX.US) With Buy Rating, Announces Target Price $8 - 富途牛牛

Jul 25, 2025
pulisher
Jul 25, 2025

Is Amneal Pharmaceuticals Inc. a good long term investmentPowerful profit generation - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Amneal Pharmaceuticals prices $600 million in senior secured notes, increases term loan - Investing.com Nigeria

Jul 25, 2025
pulisher
Jul 24, 2025

What analysts say about Amneal Pharmaceuticals Inc. stockFree Investment Community - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Amneal Pharmaceuticals prices $600 million in senior secured notes, increases term loan By Investing.com - Investing.com South Africa

Jul 24, 2025
pulisher
Jul 24, 2025

Why Investors Shouldn't Be Surprised By Amneal Pharmaceuticals, Inc.'s (NASDAQ:AMRX) Low P/S - simplywall.st

Jul 24, 2025
pulisher
Jul 22, 2025

Amneal Announces Proposed Refinancing of Existing Credit - GlobeNewswire

Jul 22, 2025
pulisher
Jul 21, 2025

Amneal Reports Certain Preliminary Second Quarter 2025 Financial Results - The Globe and Mail

Jul 21, 2025

Amneal Pharmaceuticals Inc (AMRX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$70.57
price down icon 0.87%
$13.79
price up icon 0.80%
$8.81
price up icon 0.80%
drug_manufacturers_specialty_generic RDY
$13.94
price down icon 1.97%
$128.91
price up icon 0.53%
$294.28
price up icon 7.13%
大文字化:     |  ボリューム (24 時間):